Literature DB >> 19308074

Vaccines, global health and social equity.

Myron M Levine1, Roy Robins-Browne.   

Abstract

Mortality rates of children less than 5 years old range from <10 per 1000 live births in industrialized countries to >100 in the world's poorest countries. The fact that in New York City infant mortality fell from approximately 140 deaths per 1000 live births in 1900 to <60 per 1000 by 1930 indicates what can be achieved through improvements in public health, such as the provision of clean piped water, sewage disposal and fresh refrigeration. For children living in impoverished conditions today, excess mortality is largely due to infectious diseases for which there are effective vaccines. Thus, certain specific vaccines can reduce mortality and morbidity, improve quality of life and contribute to economic development. However, because many vaccines and the means to deliver them are beyond the financial resources of countries with the highest childhood mortality rates, strategies have been devised to provide vaccines to the most needy populations. These strategies include initiatives by the Global Alliance for Vaccines and Immunization, the International Finance Facility for Immunization and the Advanced Market Commitment, which together with various governments, international agencies and charitable foundations are providing funds to make life-saving vaccines available to the world's most needy children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308074     DOI: 10.1038/icb.2009.15

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  14 in total

1.  Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).

Authors:  Gian Gandhi
Journal:  BMC Public Health       Date:  2015-11-30       Impact factor: 3.295

2.  Contaminated water delivery as a simple and effective method of experimental Salmonella infection.

Authors:  Hope O'Donnell; Oanh H Pham; Joseph M Benoun; Marietta M Ravesloot-Chávez; Stephen J McSorley
Journal:  Future Microbiol       Date:  2015-10-06       Impact factor: 3.165

3.  Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.

Authors:  Amanda J Griffin; Lin-Xi Li; Sabrina Voedisch; Oliver Pabst; Stephen J McSorley
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

4.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12

5.  A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact.

Authors:  Kristina Jonsson-Schmunk; Maria A Croyle
Journal:  Expert Rev Anti Infect Ther       Date:  2015-03-23       Impact factor: 5.091

Review 6.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

7.  Vaccine-induced immunity in early life.

Authors:  Tobias R Kollmann; Ofer Levy; Willem Hanekom
Journal:  Vaccine       Date:  2013-04-12       Impact factor: 3.641

8.  The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis.

Authors:  Myron M Levine; Karen L Kotloff; James P Nataro; Khitam Muhsen
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

9.  The case for launch of an international DNA-based birth cohort study.

Authors:  Igor Rudan; Mickey Chopra; Yurii Aulchenko; Abdullah H Baqui; Zulfiqar A Bhutta; Karen Edmond; Bernardo L Horta; Keith P Klugman; Claudio F Lanata; Shabir A Madhi; Harish Nair; Zeshan Qureshi; Craig Rubens; Evropi Theodoratou; Cesar G Victora; Wei Wang; Martin W Weber; James F Wilson; Lina Zgaga; Harry Campbell
Journal:  J Glob Health       Date:  2011-06       Impact factor: 4.413

10.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.